XORI Corp — Form D
XORI Corp of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2009-05-15. The offering totals $4.5M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-05-15
- Form: D
- Accession: 0001463974-09-000001
- Industry: Biotechnology
- Exemptions: 05
- Total offering: $4.5M
- Amount sold: $2.1M
- Remaining: $2.4M
- Investors: 9
- Date of first sale: 2009-05-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-131262
Issuer
- Name: XORI Corp
- CIK: 0001463974
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2009
- Address: 1616 EAST LAKE AVE, E, SEATTLE, WA, 98102
- Phone: 206-957-7300
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Steve Gillis | Director | New York, NY |
| Chad Waite | Director | SEATTLE, WA |
| THONG LE | Director | Seattle, WA |
| LINDSAY RAYLE | Executive Officer | New York, NY |
| David Schubert | Executive Officer | New York, NY |
| Fred Eshelman | Director | Alexandria, VA |
| Carl Weissman | Director | San Diego, CA |
| Nancy Maizels | Director | Seattle, WA |
| Stuart J Mackey | Director | Seattle, WA |
Other filings by this issuer (1)
More